ASEP Medical Holdings Inc.

ASEP

CA04368A1057

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange Other stock markets 12:21:37 2024-07-09 pm EDT			5-day change	1st Jan Change
0.17 ^CAD	0.00%		+41.67%	-17.07%

May. 29	ASEP Medical Holdings Inc. has filed an IPO in the amount of $17.25 million.	CI
Feb. 28	Asep Medical Says Its Sepsis Diagnostic Technology Can Provide Improved Odds for Pediatric Appendicitis	MT

ASEP Medical Holdings Inc. has filed an IPO in the amount of $17.25 million.

May 29, 2024 at 12:00 am EDT

ASEP Medical Holdings Inc. has filed an IPO in the amount of $17.25 million.

Security Name: Units
Security Type: Equity/Derivative Unit

Transaction Features: Sponsor Backed Offering

Latest news about ASEP Medical Holdings Inc.

ASEP Medical Holdings Inc. has filed an IPO in the amount of $17.25 million.	May. 29	CI
Asep Medical Says Its Sepsis Diagnostic Technology Can Provide Improved Odds for Pediatric Appendicitis	Feb. 28	MT
ASEP Medical Holdings Inc. announced that it expects to receive CAD 1.5 million in funding	Jan. 25	CI
ASEP Medical Holdings Reports Settlement of Debt; Down 6.8%	Dec. 29	MT
ASEP Medical Holdings Reports Settlement of Debt	Dec. 29	MT
ASEP Medical Holdings Inc. announced that it expects to receive CAD 2 million in funding	Nov. 29	CI
ASEP Medical Holdings Granted Patent Approval for its AI-based Sepsis Diagnostic Technology in the US	Nov. 27	MT
Asep Medical Holdings Inc. is Granted Patent Approval for its AI-based Sepsis Diagnostic Technology in the US	Nov. 24	CI
ASEP Medical Holdings Signs JV Agreement with Chinese Medical Diagnostics Co Sansure Biotech Inc.	Nov. 22	MT
Asep Inc. Brief: Said Overnight Monday It Completed Submission of Registration Statement for NASDAQ Listing	23-07-04	MT
ASEP Medical Holdings Receives $200k Grant from NanoMedicines Innovation Network Funded by the Government of Canada	23-06-26	MT
ASEP Medical Holdings Inc. Announces Addition of Louise Rose Pacini to its Advisory Board	23-06-20	CI
ASEP Medical Holdings Down Near 4% As Says Finalizing NASDAQ Listing	23-06-19	MT
ASEP Medical Holdings Finalizing NASDAQ Listing	23-06-19	MT
Asep Inc. Higher After Signing Definitive Agreement for JV with Bahrain-based Seaspring W.L.L	23-06-12	MT
Asep Inc. Signs Definitive Agreement for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa	23-06-09	CI
Asep Inc. Reports "Ground-breaking" AI Technology to Rapidly Identify Severe Sepsis	23-06-05	MT
Asep Inc. Brief: Up 30% After Announcing "Ground-breaking" A.I. Technology for Rapid Identification of Severe Sepsis and Improved Superbug Therapies	23-06-05	MT
Asep Medical Holdings Inc. Announces Ground-Breaking A.I. Technology for Rapid Identification of Severe Sepsis and Improved Superbug Therapies	23-06-02	CI
Asep Inc. Brief: Up Near 20% As Engages Aegis Capital Corporation for Listing on NASDAQ Stock Exchange	23-05-31	MT
Asep Medical Holdings Inc. Announces Executive Changes	23-03-06	CI
Asep Inc. Lower After Signing JV Term Sheet with Leading Chinese Medical Diagnostic Co. Sansure Biotech Inc.	23-01-30	MT
ASEP Medical Holdings Inc. Signs Joint Venture Term Sheet with Sansure Biotech Inc. in Preparation for the Commercialization of the Sepset(ER) Sepsis Diagnostic Test in China	23-01-27	CI
Asep Medical Signs LOI for JV With Bahrain Consultancy Seaspring For Commercialization of Sepsis Diagnosis Technology	23-01-09	MT
Asep Medical Holdings Inc. Signs Letter of Intent for Joint Venture with Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa	23-01-06	CI

Chart ASEP Medical Holdings Inc.

Duration

Period

More charts

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Companyâs consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company also provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. Its technology includes diagnostic and therapeutic. It has developed a novel diagnostic assay for the early and rapid diagnosis of sepsis, based on the detection of molecular signatures of sepsis specific to the immune response, rather than the presence of a pathogen.

Sector

Biotechnology & Medical Research

Calendar

2024-08-04 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
ASEP MEDICAL HOLDINGS INC.	-17.07%	9.51M
MODERNA, INC.	+16.71%	44.48B
LONZA GROUP AG	+42.89%	40.57B
IQVIA HOLDINGS INC.	-7.92%	38.82B
ALNYLAM PHARMACEUTICALS, INC.	+33.09%	32.22B
CELLTRION, INC.	-7.10%	27.84B
ICON PUBLIC LIMITED COMPANY	+14.46%	26.79B
UNITED THERAPEUTICS CORPORATION	+46.73%	14.31B
MEDPACE HOLDINGS, INC.	+34.07%	12.7B
BIO-TECHNE CORPORATION	-7.61%	11.23B